Skip to main content
SpringerLink
Log in

Rare gene variant may account for failure to respond to LABA

  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Ortega VE, et al. Effect of rare variants in ADRB2 on risk of severe exacerbations and symptom control during longacting [beta] agonist treatment in a multiethnic asthma population: a genetic study. The Lancet Respiratory Medicine : [10 pages], 27 Jan 2014. Available from: URL: http://dx.doi.org/10.1016/S2213-2600(13)70289-3.

  2. Wake Forest University Baptist Medical Center. Rare Genetic Variations May Account for Severe Reaction to LABA Drugs in Some Asthmatics. Media Release : 27 Jan 2014. Available from: URL: http://www.wakehealth.edu.

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Rare gene variant may account for failure to respond to LABA. Reactions Weekly 1489, 5 (2014). https://doi.org/10.1007/s40278-014-8893-1

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-014-8893-1

Search

Navigation